Regulation of the sleep-waking cycle is complex.
18—21 Onset of sleep is governed by the interacting forces of the sleep drive, which steadily increases with duration of wakefulness, and circadian fluctuations in arousal level. The ascending arousal system is comprised of multiple ascending projections from brainstem, hypothalamus, thalamus and basal forebrain (
+Figure 1A). There is interplay among many neurotransmitter systems to maintain the waking state, as recently reviewed.
+18—+21 Wakefulness-promoting actions of acetylcholine (midbrain, pons and basal forebrain areas,
+Figure 1 light orange), dopamine (substantia nigra and ventral tegmental area,
+Figure 1 green), and norepinephrine (locus coeruleus nucleus,
+Figure 1 purple) are well known. Recent work indicates that serotonin (dorsal raphe nucleus,
+Figure 1 yellow), histamine (tuberomammillary nucleus,
+Figure 1 red), and orexin (also called hypocretin, lateral hypothalamic area,
+Figure 1 blue) also promote wakefulness. Sleep-promoting regions in the anterior hypothalamus (principally the ventrolateral preoptic area,
+Figure 1B pink) utilize the neurotransmitters GABA and galanin to inhibit wake-promoting regions in the hypothalamus and brainstem during slow wave sleep (SWS, also called non REM (NREM) sleep) (
+Figure 1B). Brainstem regions inhibited during wakefulness and NREM sleep become active during REM sleep (
+Figure 1C). Ascending projections from cholinergic neurons in the brainstem (laterodorsal tegmental and pendunculopontine areas,
+Figure 1C light orange) activate the thalamus which in turn activates the cortex. Descending projections from this area, utilizing other neurotransmitters in addition to acetylcholine, inhibit motor neurons, producing atonia (
+Figure 1C light orange). Further complexity has been introduced by the recognition that sleep-promoting substances (somnogens) accumulate during wakefulness. Synthesis of adenosine (which appears to directly inhibit wake-promoting neurons), for example, increases during periods of high metabolic demand (e.g., prolonged wakefulness, seizures, ischemia). The wake-promoting effect of caffeine is probably due to its ability to block adenosine receptors.